FDA Recalls Irbesartan Over Potential Cancer Risk

Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According to the United States Food and Drug Administration (FDA), a pharmaceutical manufacturer has recalled multiple lots of Irbesartan. These drugs, …